Benzene-induced bone-marrow toxicity: A hematopoietic stem-cell-specific, aryl hydrocarbon receptor-mediated adverse effect

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 252-258

  Hirabayashi, Yoko ^a   Inoue, Tohru ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Common gene expressions; Global gene expression profiles; Hematopoietic progenitor cells; Hematopoietic stem cells; Stochastic signalings

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZENE; BETA2 INTEGRIN; MYOCYTE ENHANCER FACTOR 2; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RUNX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; C3H MOUSE; C57BL 6 MOUSE; CELL FRACTIONATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOTOXICITY; HEMATOPOIETIC STEM CELL; LYMPHOCYTE DIFFERENTIATION; MOLECULAR STABILITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; SERIAL ANALYSIS OF GENE EXPRESSION; STEADY STATE; STEM CELL NICHE; UPREGULATION; WILD TYPE;

ANIMALS; BENZENE; BLOOD CELLS; BONE MARROW; FEMALE; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, ARYL HYDROCARBON; STEM CELLS;

MUS;

EID: 77950628719     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.12.022     Document Type: Article

References (48)

1. Yoon B.I., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kanno J., Kim D.Y., Fujii-Kuriyama Y., Inoue T. Aryl hydrocarbon receptor mediates benzene-induced hematotoxicity. Toxicol. Sci. 2002, 70(1):150-156.
2. Hirabayashi Y., Yoon B.I., Li G.X., Kaneko T., Kanno J., Fujii-Kuriyama Y., Inoue T. AhR-mediated benzene-induced hematopoietic toxicities: differential toxicities between one from AhR in the hematopoietic stem cells for the bone marrow and the other from possible hepatic-AhR for the peripheral blood. Organohalogen Compounds 2008, 70:287-290.
3. Yoon B.I., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kim D.Y., Inoue T. Mechanism of action of benzene toxicity: cell cycle suppression in hemopoietic progenitor cells (CFU-GM). Exp. Hematol. 2001, 29(3):278-285.
4. Hirabayashi Y., Yoon B.I., Li G.X., Fujii-Kuriyama Y., Kaneko T., Kanno J., Inoue T. Benzene-induced hematopoietic toxicity transmitted by AhR in wild-type mouse and nullified by repopulation with AhR-deficient bone marrow cells: time after benzene treatment and recovery. Chemosphere 2008, 73(Suppl. 1):S290-294.
5. Yoon B.I., Li G.X., Kitada K., Kawasaki Y., Igarashi K., Kodama Y., Inoue T., Kobayashi K., Kanno J., Kim D.Y., Hirabayashi Y. Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue. Environ. Health Perspect. 2003, 111(11):1411-1420.
6. Faiola B., Fuller E.S., Wong V.A., Recio L. Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene. Mutat. Res. 2004, 549(1-2):195-212.
7. Scott L.M., Priestley G.V., Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol. Cell Biol. 2003, 23(24):9349-9360.
8. Becker P.S., Nilsson S.K., Li Z., Berrios V.M., Dooner M.S., Cooper C.L., Hsieh C.C., Quesenberry P.J. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp. Hematol. 1999, 27(3):533-541.
9. Gekas C., Rhodes K.E., Gereige L.M., Helgadottir H., Ferrari R., Kurdistani S.K., Montecino-Rodriguez E., Bassel-Duby R., Olson E., Krivtsov A.V., Armstrong S., Orkin S.H., Pellegrini M., Mikkola H.K. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. Blood 2009, 113(15):3461-3471.
10. Gerstein R.M. Deciding the decider: Mef2c in hematopoiesis. Nat. Immunol. 2009, 10(3):235-236.
11. Stehling-Sun S., Dade J., Nutt S.L., DeKoter R.P., Camargo F.D. Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c. Nat. Immunol. 2009, 10(3):289-296.
12. Burns C.E., Traver D., Mayhall E., Shepard J.L., Zon L.I. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 2005, 19(19):2331-2342.
13. Miura Y., Miura M., Gronthos S., Allen M.R., Cao C., Uveges T.E., Bi Y., Ehirchiou D., Kortesidis A., Shi S., Zhang L. Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(39):14022-14027.
14. Reuss-Borst M.A., Ning Y., Klein G., Muller C.A. The vascular cell adhesion molecule (VCAM-1) is expressed on a subset of lymphoid and myeloid leukaemias. Br. J. Haematol. 1995, 89(2):299-305.
15. Passam F.H., Tsirakis G., Boula A., Fragou A., Consolas I., Alegakis A., Kyriakou D.S., Alexandrakis M.G. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. Clin. Lab. Haematol. 2004, 26(6):391-395.
16. Wagner W., Roderburg C., Wein F., Diehlmann A., Frankhauser M., Schubert R., Eckstein V., Ho A.D. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 2007, 25(10):2638-2647.
17. Srinivasan R.S., de Erkenez A.C., Hemenway C.S. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor. Oncogene 2003, 22(22):3395-3406.
18. Mimura J., Yamashita K., Nakamura K., Morita M., Takagi T.N., Nakao K., Ema M., Sogawa K., Yasuda M., Katsuki M., Fujii-Kuriyama Y. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 1997, 2(10):645-654.
19. Cronkite E.P., Bullis J., Inoue T., Drew R.T. Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 1984, 75(2):358-361.
20. Li G.X., Hirabayashi Y., Yoon B.I., Kawasaki Y., Tsuboi I., Kodama Y., Kurokawa Y., Yodoi J., Kanno J., Inoue T. Thioredoxin overexpression in mice, model of attenuation of oxidative stress, prevents benzene-induced hemato-lymphoid toxicity and thymic lymphoma. Exp. Hematol. 2006, 34:1687-1697.
21. Kawasaki Y., Hirabayashi Y., Kaneko T., Kanno J., Kodama Y., Matsushima Y., Ogawa Y., Saitoh M., Sekita K., Uchida O., Umemura T., Yoon B.I., Inoue T. Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice. Toxicol. Sci. 2009, 110(2):293-306.
22. NTP Toxicology and Carcinogenesis Studies of Benzene (CAS No.71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies) Natl. Toxicol. Program Tech. Rep. Ser. 1986, 1-277.
23. French J.E., Lacks G.D., Trempus C., Dunnick J.K., Foley J., Mahler J., Tice R.R., Tennant R.W. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. Carcinogenesis 2001, 22(1):99-106.
24. Hirabayashi Y., Inoue T., Suda Y., Aizawa S., Ikawa Y., Kanisawa M. Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay. Exp. Hematol. 1992, 20(2):167-172.
25. Till J.E., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 1961, 14:213-222.
26. Hirabayashi Y., Matsuda M., Aizawa S., Kodama Y., Kanno J., Inoue T. Serial transplantation of p53-deficient hemopoietic progenitor cells to assess their infinite growth potential. Exp. Biol. Med. (Maywood) 2002, 227(7):474-479.
27. Hirabayashi Y., Matsumura T., Matsuda M., Kuramoto K., Motoyoshi K., Yoshida K., Sasaki H., Inoue T. Cell kinetics of hemopoietic colony-forming units in spleen (CFU-S) in young and old mice. Mech. Ageing Dev. 1998, 101(3):221-231.
28. Hirabayashi Y., Tsuboi I., Kitada K., Igarashi K., Kodama Y., Kanno J., Yoshida K., Dainiak N., Inoue T. Comparison of murine gene expression profiles between spontaneous and radiation-induced myelogenous leukemias: stochastic and probabilistic expression variances in the former vs radiation-specific expression commonalities in the latter. Exp. Hematol. 2009, 37(2):195-205.
29. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., Lemischka I.R. A stem cell molecular signature. Science 2002, 298(5593):601-604.
30. Bernauer U., Vieth B., Ellrich R., Heinrich-Hirsch B., Janig G.R., Gundert-Remy U. CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals. Arch. Toxicol. 2000, 73(12):618-624.
31. Cronkite E.P., Inoue T., Carsten A.L., Miller M.E., Bullis J.E., Drew R.T. Effects of benzene inhalation on murine pluripotent stem cells. J. Toxicol. Environ. Health 1982, 9(3):411-421.
32. Y. Hirabayashi, Benzene-induced toxicity is based on the AhR-mediated hematopoietic stem cells, Benzene 2009, Munich, 2009.
33. Hirabayashi Y., Li G.X., Yoon B.I., Fujii-Kuriyama Y., Kaneko T., Kanno J., Inoue T. AhR suppresses hemopoiesis during steady state but accelerates cell cycle as an early response: a study of AhR-knockout mice. Organohalogen Compounds 2003, 64:270-273.
34. Sudo K., Ema H., Morita Y., Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 2000, 192(9):1273-1280.
35. Ireland R.C., Li S.Y., Dougherty J.J. The DNA binding of purified Ah receptor heterodimer is regulated by redox conditions. Arch. Biochem. Biophys. 1995, 319(2):470-480.
36. Novitch B.G., Spicer D.B., Kim P.S., Cheung W.L., Lassar A.B. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 1999, 9(9):449-459.
37. Puri P.L., Sartorelli V., Yang X.J., Hamamori Y., Ogryzko V.V., Howard B.H., Kedes L., Wang J.Y., Graessmann A., Nakatani Y., Levrero M. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1997, 1(1):35-45.
38. Liu D., Kang J.S., Derynck R. TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J. 2004, 23(7):1557-1566.
39. Krutzfeldt M., Ellis M., Weekes D.B., Bull J.J., Eilers M., Vivanco M.D., Sellers W.R., Mittnacht S. Selective ablation of retinoblastoma protein function by the RET finger protein. Mol. Cell 2005, 18(2):213-224.
40. Kao H.Y., Verdel A., Tsai C.C., Simon C., Juguilon H., Khochbin S. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J. Biol. Chem. 2001, 276(50):47496-47507.
41. Teplyuk N.M., Galindo M., Teplyuk V.I., Pratap J., Young D.W., Lapointe D., Javed A., Stein J.L., Lian J.B., Stein G.S., van Wijnen A.J. Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors. J. Biol. Chem. 2008, 283(41):27585-27597.
42. Herroeder S., Reichardt P., Sassmann A., Zimmermann B., Jaeneke D., Hoeckner J., Hollmann M.W., Fischer K.D., Vogt S., Grosse R., Hogg N., Gunzer M., Offermanns S., Wettschureck N. Guanine nucleotide-binding proteins of the G12 family shape immune functions by controlling CD4+ T cell adhesiveness and motility. Immunity 2009, 30(5):708-720.
43. Duwel A., Eleno N., Jerkic M., Arevalo M., Bolanos J.P., Bernabeu C., Lopez-Novoa J.M. Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice. Tumour Biol. 2007, 28(1):1-8.
44. Krishnamachary B., Zagzag D., Nagasawa H., Rainey K., Okuyama H., Baek J.H., Semenza G.L. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 2006, 66(5):2725-2731.
45. Senaldi G., Varnum B.C., Sarmiento U., Starnes C., Lile J., Scully S., Guo J., Elliott G., McNinch J., Shaklee C.L., Freeman D., Manu F., Simonet W.S., Boone T., Chang M.S. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(20):11458-11463.
46. Burger R., Bakker F., Guenther A., Baum W., Schmidt-Arras D., Hideshima T., Tai Y.T., Shringarpure R., Catley L., Senaldi G., Gramatzki M., Anderson K.C. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival. Br. J. Haematol. 2003, 123(5):869-878.
47. Zou G.M., Luo M.H., Reed A., Kelley M.R., Yoder M.C. Ape1 regulates hematopoietic differentiation of embryonic stem cells through its redox functional domain. Blood 2007, 109(5):1917-1922.
48. Hirabayashi Y., Yoon B.I., Li G.X., Kanno J., Fujii-Kuriyama Y., Inoue T. Aryl hydrocarbon receptor suppresses spontaneous neoplasms and extends life span: possible mechanism implied by hematopoietic stem cell kinetics. Organohalogen Compounds 2007, 69:357-361.